BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9069109)

  • 61. ANCA: anti-neutrophil cytoplasmic antibodies and their role in vasculitis associated kidney disorders.
    Badakere SS; Pradhan VD
    Indian J Med Sci; 2002 Jul; 56(7):335-9. PubMed ID: 12645170
    [No Abstract]   [Full Text] [Related]  

  • 62. Evolving concepts about the role of antineutrophil cytoplasm autoantibodies in systemic vasculitides.
    Bajema IM; Hagen EC
    Curr Opin Rheumatol; 1999 Jan; 11(1):34-40. PubMed ID: 9894628
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.
    Cid MC; Segarra M; García-Martínez A; Hernández-Rodríguez J
    Curr Rheumatol Rep; 2004 Jun; 6(3):184-94. PubMed ID: 15134597
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of T lymphocytes in ANCA associated vasculitis: neglected or revisited?
    Kälsch AI; van der Woude FJ; Yard BA
    Clin Nephrol; 2005 Dec; 64(6):471-4. PubMed ID: 16370162
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The pathogenesis of ANCA-associated vasculitides: old hypotheses and new insights.
    Hänsch GM; Iking-Konert C; Andrassy K
    Clin Nephrol; 2005 Dec; 64(6):460-4. PubMed ID: 16370160
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis.
    Savage CO; Harper L; Holland M
    Curr Opin Rheumatol; 2002 Jan; 14(1):15-22. PubMed ID: 11790991
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systemic vasculitis with antineutrophil cytoplasmic autoantibodies (ANCA) in three dental technicians.
    Grateau G; Bachmeyer C; Kourilsky O; Gomez V; Choukroun G; Chauveau D; Noël LH; Choudat D; Séréni D
    Nephrol Dial Transplant; 1997 Mar; 12(3):578-81. PubMed ID: 9075146
    [No Abstract]   [Full Text] [Related]  

  • 68. Anti-neutrophil cytoplasmic autoantibodies: a renewed paradigm in periodontal disease pathogenesis?
    Sharma CG; Pradeep AR
    J Periodontol; 2006 Aug; 77(8):1304-13. PubMed ID: 16881799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antineutrophil cytoplasm antibodies: diversity and clinical applications.
    Noël LH; Geffriaud C; Chauveau D; Houhou S; Landais P; Kirhaoui F; Nusbaum P; Gouarin C; O'Donoghue D; Halbwachs-Mecarelli L
    Adv Nephrol Necker Hosp; 1993; 22():237-67. PubMed ID: 8427059
    [No Abstract]   [Full Text] [Related]  

  • 70. Anti-neutrophil cytoplasmic autoantibodies (ANCA) and vasculitis.
    Baslund B; Wiik A
    Clin Rev Allergy; 1994; 12(3):297-304. PubMed ID: 7804961
    [No Abstract]   [Full Text] [Related]  

  • 71. A patient with antineutrophil cytoplasmic antibody-negative pulmonary capillaritis and circulating primed neutrophils.
    Nierman DM; Kalb TH; Ornstein MH; Gil J
    Arthritis Rheum; 1995 Dec; 38(12):1855-8. PubMed ID: 8849360
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ANCA defines the clinical disease manifestations of vasculitis. The "con" side of the issue.
    Colby TV
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):227-9. PubMed ID: 8946587
    [No Abstract]   [Full Text] [Related]  

  • 73. Animal models in ANCA-vasculitis.
    Kettritz R; Yang JJ; Kinjoh K; Jennette JC; Falk RJ
    Clin Exp Immunol; 1995 Jul; 101 Suppl 1(Suppl 1):12-5. PubMed ID: 7606853
    [No Abstract]   [Full Text] [Related]  

  • 74. The induction of experimental vascular diseases by immunization with pathogenic autoantibodies.
    Krause I; Blank M; Shoenfeld Y
    Clin Exp Rheumatol; 2000; 18(2):257-61. PubMed ID: 10812503
    [No Abstract]   [Full Text] [Related]  

  • 75. Review article: Leukocyte-endothelial dysregulation in systemic small vessel vasculitis.
    Pankhurst T; Savage CO; Little MA
    Nephrology (Carlton); 2009 Feb; 14(1):3-10. PubMed ID: 19143939
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apoptosis: the central actor in the three hits that trigger anti-neutrophil cytoplasmic antibody-related systemic vasculitis.
    Esnault VL
    Nephrol Dial Transplant; 2002 Oct; 17(10):1725-8. PubMed ID: 12270975
    [No Abstract]   [Full Text] [Related]  

  • 77. New developments in pathogenesis of systemic vasculitis.
    Nowack R; Flores-Suárez LF; van der Woude FJ
    Curr Opin Rheumatol; 1998 Jan; 10(1):3-11. PubMed ID: 9448984
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ANCA and neutrophil biology.
    Hewins P; Savage CO
    Kidney Blood Press Res; 2003; 26(4):221-5. PubMed ID: 14504421
    [No Abstract]   [Full Text] [Related]  

  • 79. Antineutrophil cytoplasmic antibodies: are they pathogenic?
    Specks U
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S7-12. PubMed ID: 15675127
    [No Abstract]   [Full Text] [Related]  

  • 80. Abstracts from the 12th International Vasculitis and ANCA Workshop. June 15-18, 2005. Heidelberg, Germany.
    Kidney Blood Press Res; 2005; 28(3):155-99. PubMed ID: 16163809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.